Ireland - English - HPRA (Health Products Regulatory Authority)

elpen pharmaceutical co. inc. - salmeterol; fluticasone propionate - inhalation powder, pre-dispensed - 50/250 microgram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Ireland - English - HPRA (Health Products Regulatory Authority)

elpen pharmaceutical co. inc. - salmeterol; fluticasone propionate - inhalation powder, pre-dispensed - 50/500 microgram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

New Zealand - English - Medsafe (Medicines Safety Authority)

rex medical ltd - salmeterol xinafoate 0.0363mg equivalent to 0.025 mg salmeterol - aerosol inhaler, metered dose - 0.025 mg/dose - active: salmeterol xinafoate 0.0363mg equivalent to 0.025 mg salmeterol excipient: ethanol lecithin norflurane - asthma: meterol hfa inhaler is indicated in the regular treatment of asthma and prevention of bronchospasm in individuals aged 4 years and older with reversible obstructive airway disease, including those with symptoms of nocturnal asthma, when used in combination with a long-term asthma prevention medicine such as an inhaled corticosteroid. meterol hfa inhaler is not indicated for the treatment of acute asthma symptoms, for which a fast-acting inhaled bronchodilator (e.g. salbutamol) should be used. exercise-induced bronchospasm: meterol hfa inhaler is indicated in the regular prevention of exercise-induced bronchospasm in individuals aged 4 years and older. chronic obstructive pulmonary disease: meterol hfa inhaler is indicated in the regular maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease.

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - 25/125 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - salmeterol; fluticasone propionate - powder for inhalation - 50/250 mcg/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - 25/50 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - salmeterol; fluticasone propionate - inhalation powder, pre-dispensed - 50 microg/500 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

European Union - English - EMA (European Medicines Agency)

teva b.v. - salmeterol xinafoate, fluticasone propionate - pulmonary disease, chronic obstructive; asthma - drugs for obstructive airway diseases, - aerivio spiromax is indicated for use in adults aged 18 years and older only.asthmaaerivio spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:patients not adequately controlled on a lower strength corticosteroid combination product orpatients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist.chronic obstructive pulmonary disease (copd)aerivio spiromax is indicated for the symptomatic treatment of patients with copd, with a fev1

Ireland - English - HPRA (Health Products Regulatory Authority)

lexon (uk) ltd - salmeterol; fluticasone propionate - powder for inhalation - 50/250 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Ireland - English - HPRA (Health Products Regulatory Authority)

lexon (uk) ltd - salmeterol xinafoate; fluticasone propionate - powder for inhalation - 50/500 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone